Search research articles
Contact Us
Filters
Showing results (41-50 of 407) with videos related to
Page
of 41
Sort By:
Oncology
|
August 21, 2020
Identification of Aneuploid Circulating Tumor Cells in Soft-Tissue Sarcoma Patients: A Pilot Study
Andrea Napolitano, Alessandro Minelli, Daniele Santini, et al.
Critical Reviews in Oncology/Hematology
|
August 5, 2008
The biological properties of cetuximab
Bruno Vincenzi, Gaia Schiavon, Marianna Silletta, et al.
Oncotarget
|
September 24, 2017
Change from lung adenocarcinoma to small cell lung cancer as a mechanism of resistance to afatinib
Paolo Manca, Marco Russano, Francesco Pantano, et al.
Anti-Cancer Drugs
|
July 7, 2021
Long-term response to immuno-oncology after discontinuation for immuno-related pneumonia in metastatic renal carcinoma: a case report
Marco Stellato, Simone Foderaro, Giuseppe Tonini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2003
Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer
Daniele Santini, Bruno Vincenzi, Giuseppe Tonini, et al.
Chemotherapy
|
September 29, 2004
Recurrent thrombophlebitis in a colon cancer patient with C677T heterozygous genotype for MTHFR treated with 5-fluorouracil-based adjuvant chemotherapy
Gaia Schiavon, Bruno Vincenzi, Daniele Santini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 14, 2020
Coronavirus Disease 2019 or Lung Cancer: What Should We Treat?
Marco Russano, Fabrizio Citarella, Bruno Vincenzi, et al.
Critical Reviews in Oncology/Hematology
|
August 12, 2008
Are bisphosphonates the suitable anticancer drugs for the elderly?
Daniele Santini, Maria Elisabetta Fratto, Sara Galluzzo, et al.
Cancer Treatment Reviews
|
November 20, 2016
Overcoming dynamic molecular heterogeneity in metastatic colorectal cancer: Multikinase inhibition with regorafenib and the case of rechallenge with anti-EGFR
Andrea Sartore-Bianchi, Salvatore Siena, Giuseppe Tonini, et al.
Expert Opinion on Biological Therapy
|
January 16, 2008
Hormono-biological therapy in metastatic breast cancer: preclinical evidence, clinical studies and future directions
Giuseppe Tonini, Gaia Schiavon, Maria Elisabetta Fratto, et al.
Page
of 41
Search research articles
Search
Showing results (41-50 of 407) with videos related to
Sort By:
Page
of 41
Oncology
|
August 21, 2020
Identification of Aneuploid Circulating Tumor Cells in Soft-Tissue Sarcoma Patients: A Pilot Study
Andrea Napolitano, Alessandro Minelli, Daniele Santini, et al.
Critical Reviews in Oncology/Hematology
|
August 5, 2008
The biological properties of cetuximab
Bruno Vincenzi, Gaia Schiavon, Marianna Silletta, et al.
Oncotarget
|
September 24, 2017
Change from lung adenocarcinoma to small cell lung cancer as a mechanism of resistance to afatinib
Paolo Manca, Marco Russano, Francesco Pantano, et al.
Anti-Cancer Drugs
|
July 7, 2021
Long-term response to immuno-oncology after discontinuation for immuno-related pneumonia in metastatic renal carcinoma: a case report
Marco Stellato, Simone Foderaro, Giuseppe Tonini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2003
Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer
Daniele Santini, Bruno Vincenzi, Giuseppe Tonini, et al.
Chemotherapy
|
September 29, 2004
Recurrent thrombophlebitis in a colon cancer patient with C677T heterozygous genotype for MTHFR treated with 5-fluorouracil-based adjuvant chemotherapy
Gaia Schiavon, Bruno Vincenzi, Daniele Santini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 14, 2020
Coronavirus Disease 2019 or Lung Cancer: What Should We Treat?
Marco Russano, Fabrizio Citarella, Bruno Vincenzi, et al.
Critical Reviews in Oncology/Hematology
|
August 12, 2008
Are bisphosphonates the suitable anticancer drugs for the elderly?
Daniele Santini, Maria Elisabetta Fratto, Sara Galluzzo, et al.
Cancer Treatment Reviews
|
November 20, 2016
Overcoming dynamic molecular heterogeneity in metastatic colorectal cancer: Multikinase inhibition with regorafenib and the case of rechallenge with anti-EGFR
Andrea Sartore-Bianchi, Salvatore Siena, Giuseppe Tonini, et al.
Expert Opinion on Biological Therapy
|
January 16, 2008
Hormono-biological therapy in metastatic breast cancer: preclinical evidence, clinical studies and future directions
Giuseppe Tonini, Gaia Schiavon, Maria Elisabetta Fratto, et al.
Page
of 41